Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Vasodilator-stimulated phosphoprotein
Introduction
Vasodilator-stimulated phosphoprotein is a protein that in humans is encoded by the VASP gene.[1][2]
Function
Function
Vasodilator-stimulated phosphoprotein (VASP) is a member of the Ena-VASP protein family. Ena-VASP family members contain an N-terminal EVH1 domain that binds proteins containing E/DFPPPPXD/E motifs and targets Ena-VASP proteins to focal adhesions cell membranes. In the mid-region of the protein, family members have a proline-rich region that binds SH3 and WW domain-containing proteins. Their C-terminal EVH2 domain mediates tetramerization and binds both G and F actin. VASP is associated with filamentous actin formation and likely plays a widespread role in cell adhesion and motility. VASP may also be involved in the intracellular signaling pathways that regulate integrin–extracellular matrix interactions. VASP is regulated by the cyclic nucleotide-dependent kinases PKA and PKG.[2]
Interactions
Interactions
Vasodilator-stimulated phosphoprotein has been shown to interact with Zyxin,[3][4] Profilin 1[3], and PFN2.[3][5]
References
References
- ↑ Zimmer M, Fink T, Fischer L, Hauser W, Scherer K, Lichter P, Walter U (January 1997). “Cloning of the VASP (vasodilator-stimulated phosphoprotein) genes in human and mouse: structure, sequence, and chromosomal localization”. Genomics. 36 (2): 227–33. doi:10.1006/geno.1996.0457. PMID 8812448.
- ↑ 2.0 2.1 “Entrez Gene: VASP vasodilator-stimulated phosphoprotein”.
- ↑ 3.0 3.1 3.2 Harbeck, B; Hüttelmaier S; Schluter K; Jockusch B M; Illenberger S (October 2000). “Phosphorylation of the vasodilator-stimulated phosphoprotein regulates its interaction with actin”. J. Biol. Chem. UNITED STATES. 275 (40): 30817–25. doi:10.1074/jbc.M005066200. ISSN 0021-9258. PMID 10882740.
- ↑ Drees, B; Friederich E; Fradelizi J; Louvard D; Beckerle M C; Golsteyn R M (July 2000). “Characterization of the interaction between zyxin and members of the Ena/vasodilator-stimulated phosphoprotein family of proteins”. J. Biol. Chem. UNITED STATES. 275 (29): 22503–11. doi:10.1074/jbc.M001698200. ISSN 0021-9258. PMID 10801818.
- ↑ Reinhard, M; Giehl K; Abel K; Haffner C; Jarchau T; Hoppe V; Jockusch B M; Walter U (April 1995). “The proline-rich focal adhesion and microfilament protein VASP is a ligand for profilins”. EMBO J. ENGLAND. 14 (8): 1583–9. ISSN 0261-4189. PMC 398250. PMID 7737110.
Further reading
Further reading
- Reinhard M, Halbrügge M, Scheer U, et al. (1992). “The 46/50 kDa phosphoprotein VASP purified from human platelets is a novel protein associated with actin filaments and focal contacts”. EMBO J. 11 (6): 2063–70. PMC 556672. PMID 1318192.
- Halbrügge M, Eigenthaler M, Polke C, Walter U (1992). “Protein phosphorylation regulated by cyclic nucleotide-dependent protein kinases in cell extracts and in intact human lymphocytes”. Cell. Signal. 4 (2): 189–99. doi:10.1016/0898-6568(92)90082-J. PMID 1319722.
- Reinhard M, Jouvenal K, Tripier D, Walter U (1995). “Identification, purification, and characterization of a zyxin-related protein that binds the focal adhesion and microfilament protein VASP (vasodilator-stimulated phosphoprotein)”. Proc. Natl. Acad. Sci. U.S.A. 92 (17): 7956–60. Bibcode:1995PNAS…92.7956R. doi:10.1073/pnas.92.17.7956. PMC 41265. PMID 7644520.
- Reinhard M, Giehl K, Abel K, et al. (1995). “The proline-rich focal adhesion and microfilament protein VASP is a ligand for profilins”. EMBO J. 14 (8): 1583–9. PMC 398250. PMID 7737110.
- Haffner C, Jarchau T, Reinhard M, et al. (1995). “Molecular cloning, structural analysis and functional expression of the proline-rich focal adhesion and microfilament-associated protein VASP”. EMBO J. 14 (1): 19–27. PMC 398048. PMID 7828592.
- Horstrup K, Jablonka B, Hönig-Liedl P, et al. (1994). “Phosphorylation of focal adhesion vasodilator-stimulated phosphoprotein at Ser157 in intact human platelets correlates with fibrinogen receptor inhibition”. Eur. J. Biochem. 225 (1): 21–7. doi:10.1111/j.1432-1033.1994.00021.x. PMID 7925440.
- Butt E, Abel K, Krieger M, et al. (1994). “cAMP- and cGMP-dependent protein kinase phosphorylation sites of the focal adhesion vasodilator-stimulated phosphoprotein (VASP) in vitro and in intact human platelets”. J. Biol. Chem. 269 (20): 14509–17. PMID 8182057.
- Laurent V, Loisel TP, Harbeck B, et al. (1999). “Role of proteins of the Ena/VASP family in actin-based motility of Listeria monocytogenes”. J. Cell Biol. 144 (6): 1245–58. doi:10.1083/jcb.144.6.1245. PMC 2150578. PMID 10087267.
- Bachmann C, Fischer L, Walter U, Reinhard M (1999). “The EVH2 domain of the vasodilator-stimulated phosphoprotein mediates tetramerization, F-actin binding, and actin bundle formation”. J. Biol. Chem. 274 (33): 23549–57. doi:10.1074/jbc.274.33.23549. PMID 10438535.
- Petit MM, Fradelizi J, Golsteyn RM, et al. (2000). “LPP, an actin cytoskeleton protein related to zyxin, harbors a nuclear export signal and transcriptional activation capacity”. Mol. Biol. Cell. 11 (1): 117–29. doi:10.1091/mbc.11.1.117. PMC 14761. PMID 10637295.
- Krause M, Sechi AS, Konradt M, et al. (2000). “Fyn-binding protein (Fyb)/SLP-76-associated protein (SLAP), Ena/vasodilator-stimulated phosphoprotein (VASP) proteins and the Arp2/3 complex link T cell receptor (TCR) signaling to the actin cytoskeleton”. J. Cell Biol. 149 (1): 181–94. doi:10.1083/jcb.149.1.181. PMC 2175102. PMID 10747096.
- Drees B, Friederich E, Fradelizi J, et al. (2000). “Characterization of the interaction between zyxin and members of the Ena/vasodilator-stimulated phosphoprotein family of proteins”. J. Biol. Chem. 275 (29): 22503–11. doi:10.1074/jbc.M001698200. PMID 10801818.
- Smolenski A, Poller W, Walter U, Lohmann SM (2000). “Regulation of human endothelial cell focal adhesion sites and migration by cGMP-dependent protein kinase I”. J. Biol. Chem. 275 (33): 25723–32. doi:10.1074/jbc.M909632199. PMID 10851246.
- Harbeck B, Hüttelmaier S, Schluter K, et al. (2000). “Phosphorylation of the vasodilator-stimulated phosphoprotein regulates its interaction with actin”. J. Biol. Chem. 275 (40): 30817–25. doi:10.1074/jbc.M005066200. PMID 10882740.
- Burkhardt M, Glazova M, Gambaryan S, et al. (2000). “KT5823 inhibits cGMP-dependent protein kinase activity in vitro but not in intact human platelets and rat mesangial cells”. J. Biol. Chem. 275 (43): 33536–41. doi:10.1074/jbc.M005670200. PMID 10922374.
- Ball LJ, Kühne R, Hoffmann B, et al. (2000). “Dual epitope recognition by the VASP EVH1 domain modulates polyproline ligand specificity and binding affinity”. EMBO J. 19 (18): 4903–14. doi:10.1093/emboj/19.18.4903. PMC 314220. PMID 10990454.
- Bearer EL, Prakash JM, Manchester RD, Allen PG (2001). “VASP protects actin filaments from gelsolin: an in vitro study with implications for platelet actin reorganizations”. Cell Motil. Cytoskeleton. 47 (4): 351–64. doi:10.1002/1097-0169(200012)47:4<351::AID-CM8>3.0.CO;2-8. PMC 3376085. PMID 11093254.
- Lawrence DW, Pryzwansky KB (2001). “The vasodilator-stimulated phosphoprotein is regulated by cyclic GMP-dependent protein kinase during neutrophil spreading”. J. Immunol. 166 (9): 5550–6. doi:10.4049/jimmunol.166.9.5550. PMID 11313394.
- Castellano F, Le Clainche C, Patin D, et al. (2001). “A WASp-VASP complex regulates actin polymerization at the plasma membrane”. EMBO J. 20 (20): 5603–14. doi:10.1093/emboj/20.20.5603. PMC 125672. PMID 11598004.